- Despite accelerating revenue, the shares were slaughtered on new financing.
- From a revenue growth perspective, things look very good, but the company is still bleeding cash and that’s not going to change anytime soon.
- If operational cost don’t increase a whole lot more from the current $100M level, the company has cash for another 5-6 quarters; they will still need more financing.
- There will come a moment when the cash bleed will greatly diminish and with it the need for additional financing, but that still seems a couple of years off.
Senseonics Is Hitting An Inflection Point
July 20th, 2019 · No Comments